News

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.
Todd Engels, 62, from Maryland, started taking Ozempic after he saw glowing headlines and slick ads praising it as a 'miracle ...
A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.
The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.
Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...
Experts share why a diet rich in plant-based, nutrient-dense foods is key to staying healthy when using medications that curb ...
Some users of GLP-1 weight-loss drugs have been reporting strange changes in food preferences, such as a new dislike for ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Novo Nordisk partners with telehealth ...
Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...
Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would ...
Deals with Hims & Hers, LifeMD and Ro follow dismissal of a lawsuit that challenged the FDA's determination Wegovy is no ...
Hims & Hers Health Inc. soared after Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply ...